Recent Quarter Total Invested
$5.49 M
Recent Quarter Institutional Ownership Percentage
29.56%
Total Invested of Last Quarter
$7.73 M
Ownership Percentage of Last Quarter
29.29%
TherapeuticsMD, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RUBRIC CAPITAL MANAGEMENT LP | 08/13/2024 | 1.19 M | $1.92 M | 0.00% | 10.34% |
CLEARLINE CAPITAL LP | 08/15/2024 | 636,622 | $1.02 M | 18.92% | 5.52% |
TEJARA CAPITAL LTD | 08/14/2024 | 401,937 | $647,119 | 0.00% | 3.49% |
VANGUARD GROUP INC | 08/13/2024 | 387,582 | $624,007 | 0.00% | 3.36% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 270,160 | $434,958 | -0.73% | 2.34% |
MORGAN STANLEY | 10/17/2024 | 131,601 | $211,877 | -0.07% | 1.14% |
BLACKROCK INC. | 08/13/2024 | 125,152 | $201,495 | -7.83% | 1.09% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 95,477 | $153,758 | 12.61% | 0.83% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 34,000 | $54,740 | -13.04% | 0.29% |
STATE STREET CORP | 08/14/2024 | 30,100 | $48,461 | 0.00% | 0.26% |
AMERIPRISE FINANCIAL INC | 08/14/2024 | 22,470 | $36,177 | 0.00% | 0.19% |
NORTHERN TRUST CORP | 08/14/2024 | 16,457 | $26,496 | 0.00% | 0.14% |
TWO SIGMA SECURITIES, LLC | 08/14/2024 | 14,359 | $23,118 | 100.00% | 0.12% |
J. GOLDMAN & CO LP | 08/14/2024 | 13,562 | $21,835 | 0.00% | 0.12% |
GABELLI FUNDS LLC | 08/13/2024 | 12,000 | $19,320 | 0.00% | 0.10% |
CITADEL ADVISORS LLC | 08/14/2024 | 9,200 | $14,812 | 124.39% | 0.08% |
UBS GROUP AG | 08/14/2024 | 9,116 | $14,677 | 16.66% | 0.08% |
FMR LLC | 08/13/2024 | 8,289 | $13,345 | 0.00% | 0.07% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 3,534 | $5,690 | 115.88% | 0.03% |
CITADEL ADVISORS LLC | 08/14/2024 | 1,576 | $2,537 | -68.24% | 0.01% |
NATIONAL BANK OF CANADA /FI/ | 08/02/2024 | 610 | $1,031 | -15.28% | 0.01% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 487 | $784 | 21.75% | 0.00% |
JPMORGAN CHASE & CO | 08/12/2024 | 293 | $471 | 0.00% | 0.00% |
US BANCORP \DE\ | 08/07/2024 | 246 | $396 | -40.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 171 | $275 | -35.96% | 0.00% |
PRINCIPAL SECURITIES, INC. | 07/31/2024 | 126 | $203 | 0.00% | 0.00% |
RHUMBLINE ADVISERS | 08/01/2024 | 122 | $196 | -12.86% | 0.00% |
HUNTINGTON NATIONAL BANK | 08/08/2024 | 120 | $193 | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 08/14/2024 | 100 | $161 | -96.88% | 0.00% |
IFP ADVISORS, INC | 07/30/2024 | 80 | $129 | 33.33% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 56 | $90 | -94.59% | 0.00% |
ACTIVEST WEALTH MANAGEMENT | 07/30/2024 | 40 | $64 | 100.00% | 0.00% |
HARBOUR INVESTMENTS, INC. | 07/26/2024 | 8 | $13 | 0.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 2 | $4 | 0.00% | 0.00% |
GUARDIAN WEALTH MANAGEMENT, INC. | 08/08/2024 | 2 | $3 | 0.00% | 0.00% |
EVERSOURCE WEALTH ADVISORS, LLC | 08/13/2024 | 1 | $2 | 0.00% | 0.00% |
ASPIRE PRIVATE CAPITAL, LLC | 07/15/2024 | 1 | $2 | 0.00% | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
OLD POINT TRUST & FINANCIAL SERVICES N A | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
ASSETMARK, INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
CLEAR HARBOR ASSET MANAGEMENT, LLC | 07/17/2024 | 0 | $0 | -100.00% | 0.00% |
BANQUE CANTONALE VAUDOISE | 07/31/2024 | 0 | $0 | -100.00% | 0.00% |
PROSPERITY CONSULTING GROUP, LLC | 08/08/2024 | 0 | $0 | -100.00% | 0.00% |
TherapeuticsMD, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of TXMD shares?
During the previous two years, 21 institutional investors and hedge funds held shares of TherapeuticsMD, Inc.. The most heavily invested institutionals were:
GABELLI FUNDS LLC: 0
TWO SIGMA SECURITIES, LLC: 0
Qube Research & Technologies Ltd: 0
MORGAN STANLEY: 131,601
BlackRock Inc.: 125,152
GEODE CAPITAL MANAGEMENT, LLC: 95,477
-
What percentage of TherapeuticsMD, Inc. stock is owned by institutional investors?
29.56% of TherapeuticsMD, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at TXMD ?
Institutional investors have bought a total of 502,219 shares in the last 24 months. This purchase volume represents approximately $642,840 in transactions.